Clinical Trial Update: Study to Evaluate Pharmacokinetics of ITCA 650 in Subjects With Renal Impairment Compared to Normal Subjects [Phase 1]

View source ↗

Summary

This completed Phase 1 study evaluated the pharmacokinetics of ITCA 650 in subjects with renal impairment compared to those with normal renal function.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Insufficiency

Drugs mentioned

• ITCA 650

Snippet

Sponsor: Intarcia Therapeutics | Conditions: Renal Insufficiency | Phase 1 | Status: COMPLETED